Hologic - News Releases http://investors.hologic.com/ Hologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on Wednesday, May 10, 2017 http://investors.hologic.com/2017-04-04-Hologic-to-Announce-Financial-Results-for-the-Second-Quarter-of-Fiscal-2017-on-Wednesday-May-10-2017 Tue, 04 Apr 2017 16:01:00 -0400 http://investors.hologic.com/2017-04-04-Hologic-to-Announce-Financial-Results-for-the-Second-Quarter-of-Fiscal-2017-on-Wednesday-May-10-2017 Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert http://investors.hologic.com/2017-04-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Mon, 03 Apr 2017 16:01:00 -0400 http://investors.hologic.com/2017-04-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Hologic Completes Acquisition of Cynosure http://investors.hologic.com/2017-03-22-Hologic-Completes-Acquisition-of-Cynosure -- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate -- Wed, 22 Mar 2017 09:00:00 -0400 http://investors.hologic.com/2017-03-22-Hologic-Completes-Acquisition-of-Cynosure Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 http://investors.hologic.com/ECR2017 --Comprehensive suite of transformative products spotlights Hologic’s ongoing dedication to innovation and the advancement of breast health -- Wed, 01 Mar 2017 10:53:00 -0500 http://investors.hologic.com/ECR2017 FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay http://investors.hologic.com/2017-02-15-FDA-Grants-PMA-Approval-for-Hologics-Aptima-R-Hepatitis-C-Quant-Dx-Assay HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Wed, 15 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-15-FDA-Grants-PMA-Approval-for-Hologics-Aptima-R-Hepatitis-C-Quant-Dx-Assay Hologic's Aptima® Zika Virus Assay Now CE Marked in Europe http://investors.hologic.com/news?item=641 --New Diagnostic Test Available for Use on the Panther System-- Tue, 14 Feb 2017 09:00:00 -0500 http://investors.hologic.com/news?item=641 Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses http://investors.hologic.com/2017-02-14-Hologic-to-Acquire-Cynosure-Leader-in-Medical-Aesthetics-Systems-and-Technologies-in-All-Cash-Tender-Offer-that-Combines-Two-Complementary-Businesses -Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate - Tue, 14 Feb 2017 08:00:00 -0500 http://investors.hologic.com/2017-02-14-Hologic-to-Acquire-Cynosure-Leader-in-Medical-Aesthetics-Systems-and-Technologies-in-All-Cash-Tender-Offer-that-Combines-Two-Complementary-Businesses Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-02-09-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Thu, 09 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-09-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System for the Treatment of Abnormal Uterine Bleeding http://investors.hologic.com/2017-02-02-Hologic-Launches-Next-Generation-NovaSure-R-ADVANCED-Global-Endometrial-Ablation-System-for-the-Treatment-of-Abnormal-Uterine-Bleeding --Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- Thu, 02 Feb 2017 08:00:00 -0500 http://investors.hologic.com/2017-02-02-Hologic-Launches-Next-Generation-NovaSure-R-ADVANCED-Global-Endometrial-Ablation-System-for-the-Treatment-of-Abnormal-Uterine-Bleeding Hologic Announces Financial Results for First Quarter of Fiscal 2017 http://investors.hologic.com/2017-02-01-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2017 -- GAAP Diluted EPS of $0.30 Increases 3.4%, Non-GAAP Diluted EPS of $0.52 Increases 13.0% -- Wed, 01 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-01-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2017 Hologic Completes Divestiture of Blood Screening Business http://investors.hologic.com/2017-01-31-Hologic-Completes-Divestiture-of-Blood-Screening-Business - Strengthens Efforts to Build a Sustainable Growth Company - Tue, 31 Jan 2017 16:01:00 -0500 http://investors.hologic.com/2017-01-31-Hologic-Completes-Divestiture-of-Blood-Screening-Business Hologic Recognizes Cervical Health Awareness Month and Emphasizes Importance of Early Diagnosis to Reduce Cervical Cancer http://investors.hologic.com/news?item=636 Fri, 13 Jan 2017 11:15:00 -0500 http://investors.hologic.com/news?item=636 Hologic to Announce Financial Results for the First Quarter of Fiscal 2017 on Wednesday, February 1, 2017 http://investors.hologic.com/2017-01-05-Hologic-to-Announce-Financial-Results-for-the-First-Quarter-of-Fiscal-2017-on-Wednesday-February-1-2017 Thu, 05 Jan 2017 16:01:00 -0500 http://investors.hologic.com/2017-01-05-Hologic-to-Announce-Financial-Results-for-the-First-Quarter-of-Fiscal-2017-on-Wednesday-February-1-2017 Hologic Appoints President of EMEA and Canada, Completing International Leadership Team http://investors.hologic.com/2017-01-04-Hologic-Appoints-President-of-EMEA-and-Canada-Completing-International-Leadership-Team Wed, 04 Jan 2017 16:01:00 -0500 http://investors.hologic.com/2017-01-04-Hologic-Appoints-President-of-EMEA-and-Canada-Completing-International-Leadership-Team FDA Grants PMA Approval for Hologic's Aptima® HIV-1 Quant Assay http://investors.hologic.com/2017-01-03-FDA-Grants-PMA-Approval-for-Hologics-Aptima-HIV-1-Quant-Assay --High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system-- Tue, 03 Jan 2017 08:00:00 -0500 http://investors.hologic.com/2017-01-03-FDA-Grants-PMA-Approval-for-Hologics-Aptima-HIV-1-Quant-Assay Hologic to Present at the 35th Annual J.P. Morgan Healthcare Conference http://investors.hologic.com/2016-12-20-Hologic-to-Present-at-the-35th-Annual-J-P-Morgan-Healthcare-Conference Tue, 20 Dec 2016 16:01:00 -0500 http://investors.hologic.com/2016-12-20-Hologic-to-Present-at-the-35th-Annual-J-P-Morgan-Healthcare-Conference Amy Wendell Elected to Hologic Board of Directors http://investors.hologic.com/2016-12-16-Amy-Wendell-Elected-to-Hologic-Board-of-Directors Fri, 16 Dec 2016 08:00:00 -0500 http://investors.hologic.com/2016-12-16-Amy-Wendell-Elected-to-Hologic-Board-of-Directors Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion http://investors.hologic.com/2016-12-14-Hologic-to-Divest-Blood-Screening-Business-to-Partner-Grifols-for-1-85-Billion - Transaction Strengthens Hologic's Efforts to Build a Sustainable Growth Company - Wed, 14 Dec 2016 16:01:00 -0500 http://investors.hologic.com/2016-12-14-Hologic-to-Divest-Blood-Screening-Business-to-Partner-Grifols-for-1-85-Billion Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 http://investors.hologic.com/2016-11-25-Hologic-to-Showcase-Award-Winning-Breast-Screening-and-Interventional-Solutions-at-RSNA-2016 --New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging-- Fri, 25 Nov 2016 08:00:00 -0500 http://investors.hologic.com/2016-11-25-Hologic-to-Showcase-Award-Winning-Breast-Screening-and-Interventional-Solutions-at-RSNA-2016 American Society for Radiation Oncology (ASTRO) Publishes New Evidence-Based Consensus Statement on Accelerated Partial Breast Irradiation (APBI) http://investors.hologic.com/news?item=628 --Hologic Applauds ASTRO for Expanding Patient Access to More Targeted, Less Time-Consuming Breast Cancer Treatment Options-- Fri, 18 Nov 2016 11:40:00 -0500 http://investors.hologic.com/news?item=628 Hologic Obtains European CE Mark for Aptima® Assay to Detect Herpes Simplex Virus 1 & 2 http://investors.hologic.com/news?item=627 --Highly Accurate HSV Test Now Available Alongside Women’s Health Menu on the Fully Automated Panther System-- Tue, 15 Nov 2016 08:01:00 -0500 http://investors.hologic.com/news?item=627 Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System to Enhance the Treatment of Abnormal Uterine Bleeding http://investors.hologic.com/news?item=625 --Smaller 6mm Diameter and Other Product Enhancements are Designed to Increase Patient Comfort and Improve Physician Ease-of-Use-- Mon, 14 Nov 2016 08:01:00 -0500 http://investors.hologic.com/news?item=625 Hologic Obtains Canadian Approval for Aptima® Hepatitis C and B Quant Assays http://investors.hologic.com/news?item=624 --Highly Accurate Viral Load Tests Complete Virology Offering in Canada and Complement Women’s Health Menu on the Fully Automated Panther System-- Thu, 10 Nov 2016 08:00:00 -0500 http://investors.hologic.com/news?item=624 Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Exchange Senior Notes Due 2037 http://investors.hologic.com/2016-11-09-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Exchange-Senior-Notes-Due-2037 Wed, 09 Nov 2016 16:01:00 -0500 http://investors.hologic.com/2016-11-09-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Exchange-Senior-Notes-Due-2037 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2016-11-07-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 07 Nov 2016 16:01:00 -0500 http://investors.hologic.com/2016-11-07-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences